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Regulation of mitochondrial activity allows cells to adapt to changing
conditions and to control oxidative stress, and its dysfunction can
lead to hypoxia-dependent pathologies such as ischemia and cancer.
Although cytochrome c phosphorylation—in particular, at tyrosine
48—is a key modulator of mitochondrial signaling, its action and
molecular basis remain unknown. Here we mimic phosphorylation
of cytochrome c by replacing tyrosine 48 with p-carboxy-methyl-
L-phenylalanine (pCMF). The NMR structure of the resulting mutant
reveals significant conformational shifts and enhanced dynamics
around pCMF that could explain changes observed in its functional-
ity: The phosphomimetic mutation impairs cytochrome c diffusion
between respiratory complexes, enhances hemeprotein peroxidase
and reactive oxygen species scavenging activities, and hinders
caspase-dependent apoptosis. Our findings provide a framework to
further investigate the modulation of mitochondrial activity by phos-
phorylated cytochrome c and to develop novel therapeutic ap-
proaches based on its prosurvival effects.
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Oxidative phosphorylation (OxPhos) relies on the electrontransport chain (ETC) to generate the membrane potential
that drives ATP synthesis (1). Components of the ETC oxidize
substrates to reduce molecular oxygen, thereby producing water.
Nevertheless, around 2% of the electrons flowing across the
ETC yield reactive oxygen species (ROS) (2). ROS are a source
of oxidative stress and act as signaling molecules at low con-
centrations (3–5). Hindering redox reactions within the distinct
ETC membrane complexes (complexes I to V) leads to enhanced
ROS production (6). The activity of the ETC is tightly regulated
by posttranslational modifications of its components, isoform
swapping, and modulation of the equilibria for the association of
the membrane protein complexes into supercomplexes (3, 7).
Such associations allow substrate channeling while modulating
ROS production (3, 7).
Oxidative stress response involves redox signals modulating
protein phosphorylation (8). In the ETC, the major phosphoryla-
tion targets are NADH:UQ oxidoreductase, cytochrome c (Cc),
and cytochrome c oxidase (CcO) (9). Besides being essential for
oxidative respiration (Fig. 1A), Cc acts as a redox regulatory pro-
tein within the mitochondrial intermembrane space (10). In addi-
tion, Cc aids in controlling ROS levels by oxidizing superoxide
anions (11) and exhibiting peroxidase activity (12); the latter,
however, also yields lipid peroxidation (13, 14). Furthermore, Cc
plays a crucial role in programmed cell death, a process that is only
partially understood (15–21). In this context, a fraction of Cc binds
and oxidizes cardiolipin (CL) at the internal mitochondrial mem-
brane, thereby facilitating the release of unbound Cc to the cyto-
plasm (16, 17). In mammalian cells, extramitochondrial Cc interacts
with apoptosis activating factor 1 (Apaf-1) in the cytoplasm to
spark the caspase proteolytic cascade (15). It has recently been
shown that Cc can interact with several other proteins outside
the mitochondria in humans and plants (18–21). The similarities
between the Cc signaling networks in both organisms suggest that
key programmed cell-death pathways are conserved throughout
evolution (22).
Cc phosphorylation is an alleged modulator of the mitochondrial
cell-death pathway (23, 24). Its deregulation is believed to be related
to the onset of neurological disorders and cancer (24). Phos-
phorylation of Cc is easily reversed by phosphatases, hampering
the isolation of the modified protein from tissues (25). Tyr-to-Glu
substitutions of Cc, designed to emulate Tyr48 phosphorylation,
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impair both the electron donation to CcO and the activation of
caspase-9 mediated by Apaf-1 in vitro (26, 27). Notably, nitration
of this residue also hinders the ability of Cc to activate Apaf-1 (28–
30). Thus, these posttranslational modifications alter both mito-
chondrial and cytoplasmic functions of Cc. Tyr48 phosphorylation
also affects the physical-chemical properties of Cc, such as its al-
kaline transition and midpoint reduction potential (E0) (27, 31).
Understanding the origin of these effects and how they affect Cc
activities requires solving the 3D conformation of the phosphory-
lated species. However, deciphering the effects of Tyr48 phosphor-
ylation on the structure and dynamics of Cc is highly challenging
because of its reactivity toward phosphatases. Indeed, no atomic-
resolution structure has been reported for either phosphorylated Cc
or any reliable mimic mutant.
Here we have elucidated the structure of a phosphomimetic Cc
variant in which Tyr48 is replaced by the synthetic, noncanonical
amino acid p-carboxy-methyl-L-phenylalanine (pCMF). We show
that such replacement induces local perturbations of the Cc
structure and enhanced internal dynamics of the mutation’s sur-
roundings. We used biochemical assays to show that the Y48pCMF
mutation impairs Cc channeling between cytochrome bc1 (Cbc1)
and CcO, enhances peroxidase activity, and induces an antiapoptotic
function of Cc.
Results
Phosphorylation of Tyr48 Induces Local Structural Changes in Cytochrome
c. To understand how phosphorylation affects the structure of hu-
man Cc, we tackled the challenge of fully characterizing the phos-
phomimetic mutant Y48pCMF Cc in its reduced form, which is the
redox state of Cc donating electrons to CcO in homeostasis and
is essential for its apoptotic activity, because Cc becomes highly
reduced upon its release from the mitochondria to the cytosol (32).
Y48pCMF Cc maintains the overall secondary structure and global
fold of wild-type (WT) Cc, as inferred from circular dichroism (CD)
(Fig. 1B) and 1H–15N heteronuclear single-quantum correlation
(HSQC) NMR spectra (Fig. 1C), respectively. Also, the native heme
axial coordination was preserved, as indicated by 1D 1H NMR data
(Fig. 1D). The NMR spectra of reduced Y48pCMF Cc were
extensively assigned: Triple-resonance experiments (SI Appendix,
Table S1) allowed us to detect and assign 91 backbone amide signals
and the sequential connectivities for most residues of the protein.
Aliphatic side-chain signals were assigned using 3DHBHA(CO)NH
and 3D HCCH-total correlation spectroscopy (TOCSY) experi-
ments, leading to the assignment of most (96.4%) of the side-chain
proton resonances. The 15N–H resonance of pCMF48 was unde-
tectable because the residue was not 15N-enriched. Four proline
residues (Pro30, Pro44, Pro71, and Pro76) interrupt the sequential
HN–HN connectivity. Additionally, in contrast toWTCc, we could
not detect the amide protons of the Thr49, Ala51, Gly56, and Ile57
residues. However, the WT spectra only had four amide protons
that could not be detected (Gly1, Glu21, Thr28, and Gly84) under
similar experimental conditions. Further, in contrast to WT Cc,
the signals from Asn31, Gly45, and Ser47 in pCMF48 Cc were
significantly weaker than the rest. The largest chemical-shift per-
turbations for backbone amides induced by the modified residue at
position 48 are confined to nearby residues (SI Appendix, Fig. S1).
Assigning 1H resonances to the heme substituents and 1H (and
13C) signals to the aromatic side chains was required for ana-
lyzing additional 2D maps (i.e., COSY and 1H–15N NOESY) (SI
Appendix, Table S1). Assignment of the Cδ1, Cδ2, Ce1, and Ce2
aromatic signals from the pCMF48 side chain required the ac-
quisition of an aromatic 1H–13C HSQC spectrum recorded in a
Fig. 1. Control of human cell fate by the Cc-based
signalosome, and biophysical and structural charac-
terization of the Y48pCMF variant of Cc. (A) Diagram
of the role of Cc in homeostasis and apoptosis. (A,
Left) Under homeostatic conditions, Cc (red circles)
transfers electrons from the cytochrome bc1 complex
(Cbc1) to the cytochrome c oxidase complex (CcO). (A,
Right) Upon apoptotic stimuli, Cc is released to the
cytosol to induce apoptosome formation and block
prosurvival pathways. A portion of Cc remains bound
to cardiolipin. (B) Far-UV CD spectra of the reduced
forms of WT (blue) and Y48pCMF Cc (red). The same
color code is maintained in the following panels.
(C) Superimposition of the 1H–15N HSQC spectra of
uniformly 15N-labeled forms of WT and Y48pCMF Cc.
Backbone amide resonances of Y48pCMF Cc are la-
beled in red and black. Particular amide resonances of
WT Cc are labeled in blue. (D) Detailed view of the 1H
NMR spectra of WT and Y48pCMF Cc at negative ppm
values. Resonances for Met80 side-chain protons are
shown for both Cc species. Assigned signals of all
residues within this region are displayed for Y48pCMF
Cc. The extra signal of WT Cc corresponds to the Qδ1
protons of Ile53. (E) Superimposition of the aromatic
region of the 1H–13C HSQC spectra ofWT and Y48pCMF
Cc acquired in 13C natural abundance. Assigned aro-
matic resonances of Y48pCMF Cc are displayed in red.
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natural abundance of 13C (Fig. 1E). The assignment of the
pCMF48 side-chain signals involved the complete assignment
of the 2D 1H–15N NOESY.
Numerous residues (Val20 to Asn31, Thr40 to Trp59, and
Ile75 to Glu90) displayed signals attributable to a second, minor
protein conformation, which had a 1:10 ratio in intensity. Hereaf-
ter, only the major form was considered for structure calculations.
We assigned 96% of all the 1H signals for the major form.
Structural information derived from 2D and 3D NOESY maps
supported the presence of five α-helical regions (labeled α1 to α5)
with typically strong HN–HN (i, i+1), medium-range Hα–HN
(i, i+3), and Hα–HN (i, i+4) interresidual NOEs. These regions
spanned the sequence stretches Val3 to Lys13, Ala50 to Asn54,
Glu61 to Glu69, Pro71 to Tyr74, and Lys88 to Thr102, resem-
bling those in the NMR structure of reduced WT Cc (33). In
total, we observed and assigned 2,176 meaningful NOEs, corre-
sponding to 20.8 relevant restraints per residue on average (SI
Appendix, Fig. S2). The 71 ϕ and 71 ψ dihedral-angle constraints
were derived from 15N, 13C′, 13Cα, 13Cβ, and Hα chemical shifts,
using TALOS+ (34). The heme moiety was included in the cal-
culations as previously reported for WT cytochromes (35, 36),
assuming an intact heme iron coordination as supported by X-ray
absorption spectroscopy (XAS) data (next section).
Two hundred structures were calculated by CYANA (37), and
the 20 structures with the lowest target-function (TF) value were
selected to form a representative family. The range of TF values
was 0.38 to 0.98 Å2, highlighting the high accuracy between cal-
culated and experimental distances. Further refinement of the
20 lowest TF structures involved restrained energy minimization
and restrained molecular dynamics (RMD) computations. A final
restrained energy minimization was carried out on the structure
with the lowest root-mean-square deviation (rmsd) from the av-
erage for each of the 20 trajectories. The overall quality of the
20 lowest TF ensembles was good, according to the PROCHECK
G factor (38), MolProbity clashscores (39), and other structural
quality indicators (SI Appendix, Table S2). Most residues were in
the Ramachandran plot favored regions, whereas Cys14, Cys17,
His18, Val20, Lys37, and Asn70 were in the generously allowed
ones, as also observed for the solution structure of WTCc (33, 40).
Cys14, Cys17, and His18 are covalently bonded to the heme
moiety, thereby straining their backbone conformation, as already
described for c-type cytochromes (35, 36). As an additional con-
trol, we performed 20-ns unrestrained molecular dynamics (MD)
simulations of the final minimized conformers without any geo-
metrical restraint. The rmsd for the main-chain atoms was about
1.55 Å at the plateau, hardly drifting (0.122 pm·ns–1), as expected
for a stable structure (SI Appendix, Fig. S3).
The overall fold of Y48pCMF Cc is very similar to that of
the WT species (SI Appendix, Fig. S4), with rmsd values for the
backbone nuclei of 1.67 ± 1.01 Å (Fig. 2 A and B). However, the
two structures differ in the mutation-containing loop ΩNY (resi-
dues 40 to 57; Fig. 2B). This is consistent with the chemical-shift
differences (SI Appendix, Fig. S1) and the rmsd between the NMR
solution structure of WT Cc [Protein Data Bank (PDB) ID code
1J3S] (33) and the refined lowest-TF Y48pCMF Cc (SI Appendix,
Fig. S5A). An increased dynamics in the ΩNY-loop has recently
been observed in the G41S variant of Cc (42). The ΩNY-loop (also
known as foldon V) and helix α2 constitute the less-stable folding
unit of Cc (43). Unlike Tyr48 in the WT species, the pCMF48
residue presents a very low number of 1H–1H NOEs (SI Appendix,
Fig. S2) and a high rmsd value within the family (Fig. 2C and SI
Appendix, Fig. S5B). A decrease in the number of detectable
NOEs can generally be attributed to either a partial assignment of
the residue or an increased internal mobility. In our case, the
highly dynamic behavior of the pCMF48 residue was confirmed
from further analysis of internal motions within the nanosecond-
to-picosecond timescale (see below).
Other regions of the Y48pCMF Cc structure that differed
from those of WT Cc belong to the 19 to 36 ΩG-loop (part of
foldon II) and the 71 to 85 ΩR-loop (foldon IV) comprising
Met80 and helix α4. The rmsd values for backbone atoms of
residues from Val20 to Gly29 of Y48pCMF Cc are higher (2.75 ±
1.50 Å) than those for the same residues of WT Cc (SI Appendix,
Fig. S5A). In the second loop, the observed differences are
mainly restricted to side chains. In fact, the rmsd values for
backbone and heavy atoms are 1.18 ± 0.37 and 1.77 ± 0.71 Å,
respectively. Residues included in the ΩR-loop indeed displayed
a double conformation, suggesting the presence of conforma-
tional equilibria (SI Appendix, Fig. S5A).
The ensemble of structures for Y48pCMF Cc is very precise,
except for residues surrounding the mutation. The backbone rmsd
from the mean is 0.89 ± 0.01 Å for the whole protein and drops to
0.53 ± 0.12 Å when the mutation surroundings are excluded
(residues 40 to 57) (SI Appendix, Fig. S5B). As expected, the
highest rmsd values correspond to the 40 to 57 ΩNY-loop and the
nearby residues Val20 to Gly29 in loop ΩG, whose global backbone
Fig. 2. NMR solution structure of the Y48pCMF variant of Cc. (A) Stereo-
view ribbon representation of the 20 best conformers of Y48pCMF Cc. Heme
group atoms are displayed for all conformers. Ribbons are colored in red,
whereas atoms from the heme group are colored following the CPK (Robert
Corey, Linus Pauling, and Walter Koltun) color scheme. Foldons of Y48pCMF
Cc are shadowed and marked with roman numerals, except for foldon III,
which is located behind foldon IV. (B) Comparison between the NMR solu-
tion structures of WT Cc (PDB ID code 1J3S) (33) and Y48pCMF Cc (this work).
The ribbon for WT Cc is in blue. The five α-helices of both Cc species, as well
as the mutation-containing loop of Y48pCMF Cc, are marked. Arrows point
to the regions on the Y48pCMF Cc ribbon with substantial structural changes
compared with the WT form. (C) Detailed view of the loop harboring the
pCMF48 residue. pCMF48 atoms follow the CPK color scheme. Protein
structures are presented by UCSF Chimera software (41). (D) Detail of the heme
group and axial ligands. Labels display iron-to-axial ligand distances for the
Y48pCMF mutant obtained from the EXAFS analysis (SI Appendix, Fig. S5).






























rmsd values were 1.79 ± 0.53 and 0.78 ± 0.23 Å, respectively.
These segments also exhibited a larger conformational variability
in their secondary structure elements along the MD trajectory (SI
Appendix, Fig. S3 B and C). High rmsd values along the Val20-to-
Gly29 stretch are typical in Cc homologs (35, 36). They are also
consistent with NMR signals revealing secondary conformations
for the His26-to-Pro30 stretch. Moreover, the nearby Asn31
amide signal is weak, suggesting high mobility. Notably, all
these residues contact the ΩNY-loop, comprising the Y48pCMF
mutation.
Further, the highest rmsd values mapped to the ΩNY-loop.
Consistently, signals from this region undergo a drastic reduction
in their 1H–1H NOE cross-peaks. The intensities of the amide
signals of Gly45 and Ser47 in Y48pCMF Cc were severely de-
creased, whereas those from Thr49, Ala51, Gly56, and Ile57 were
undetectable. The ΩR-loop also contains some residues with high
rmsd values (SI Appendix, Fig. S5B). The global rmsd value for
backbone atoms of the 71 to 85 ΩR-loop is 0.76 ± 0.20 Å. Notably,
the end of the ΩR-loop shows high rmsd values in WT cyto-
chromes (35, 36).
Heme Iron Coordination Is Insensitive to Tyr48 Phosphorylation. We
tested the effects of the mutation on the heme iron coordination
environment and the axial coordination restraints used in our
structure computations by using X-ray absorption spectroscopy,
studying both WT and Y48pCMF species (Fig. 2D and SI Ap-
pendix, Fig. S5 C–F). The absorption spectra of the two proteins
are almost identical. The X-ray absorption near-edge structure
regions of the absorption spectra for both proteins are super-
imposed (SI Appendix, Fig. S5C). The absence of any shift in the
energy position of the absorption edge indicates that the muta-
tion did not affect the electron density at the Fe center.
Likewise, the extracted extended X-ray absorption fine struc-
ture (EXAFS) signals of the WT and Y48pCMF Cc species were
highly similar. However, small differences in high wave vector (k)
values can be observed (SI Appendix, Fig. S5D), as well as in the
slightly lower amplitude of the Y48pCMF protein. Whereas the
corresponding Fourier transforms are also very similar (SI Ap-
pendix, Fig. S5E), the amplitude of the first peak is lower and
broader in the Y48pCMF Cc species, suggesting a larger degree of
disorder. The dynamic disorder for the two proteins should be
similar, as the measurements were performed at cryogenic tem-
peratures in both cases. Hence, the differences in disorder are due
to a larger static disorder in Y48pCMF Cc. The main scattering
paths contributing to this peak originate from the four nitrogen
atoms of the porphyrin ring, although contributions of the nitro-
gen and sulfur axial ligands have also been included. The fit to the
data requires the addition of the paths involving the eight por-
phyrin carbons closest to the iron atom, beyond the first co-
ordination sphere. In addition, the multiple scattering paths
involving these atoms were also included. Fits were performed in
R space but also reproduced the spectra well in q space (SI Ap-
pendix, Fig. S5F). The parameters obtained from the best fit to the
data revealed that the distances between the iron atom and its first
coordinating ligands are insensitive to the Y48pCMF mutation (SI
Appendix, Table S3). Specifically, the distances from the iron
center to the axial S ligand are 2.26 ± 0.001 and 2.25 ± 0.001 Å in
the WT and phosphomimetic mutant species, respectively (Fig.
2D). Data analyses also showed that the value for the Debye–
Waller factor corresponding to the path involving the four por-
phyrin nitrogen atoms increased from 0.0012 ± 0.0006 Å2 in the
WT species to 0.003 ± 0.001 Å2 in the Y48pCMF mutant. These
data are consistent with the preserved chemical-shift pattern of the
iron axial ligands and heme substituents observed in 1D 1H NMR
(Fig. 1D), which have been reported to be sensitive indicators of
the heme iron electronic structures (35, 36). The pattern of the
observed NOEs for the heme substituents also supports an overall
intact heme pocket, with the exception of the mutation site. Still,
the ensemble of structures shows a small change in the orientation
of Phe82 with respect to the porphyrin ring (SI Appendix, Fig. S6).
Phosphorylation of Tyr48 Enhances Internal Mobility in Cytochrome c.
NMR relaxation measurements were performed to evaluate the
dynamics of WT and Y48pCMF Cc. The Y48pCMF substitution
slightly affected both relaxation rate (R1 and R2) parameters (SI
Appendix, Table S4). The rotational correlation time of the
phosphomimetic mutant (6.96 ± 0.02 ns) was higher than that of
the WT form (6.33 ± 0.02 ns), in agreement with the small in-
crease (pnul values of ∼10−251, where pnul is the probability for
the null hypothesis being the right one) in the average gyration
radius, from 12.95 ± 0.07 to 13.04 ± 0.06 Å, as calculated by MD.
Indeed, phosphorylation can alter protein dynamics at different
timescales and cause conformational rearrangements, such as
the formation of secondary conformations (44, 45).
Comparing R1, R2, and heteronuclear NOE (HetNOE) re-
laxation measurements recorded on the two proteins revealed that
the ΩNY-loop of Y48pCMF Cc exhibits a high mobility in the
Fig. 3. Relaxation NMR measurements and dynamic properties of WT and
Y48pCMF Cc. (A–C) Differences in heteronuclear NOE (A), relaxation rate R1
(B), and relaxation rate R2 (C) between the experimental values for the re-
duced forms of WT and Y48pCMF Cc, plotted as a function of the residue
number. Gaps in data result from overlapping resonances, broadened res-
onances beyond the detection limit, and unassigned resonances. A scheme
of the secondary structure elements is included (Top). (D) Map of the
Y48pCMF Cc residues colored according to their dynamic properties. Af-
fected residues in the heteronuclear NOE and relaxation rate R2 parameters
are colored in yellow and orange, respectively. Residues with backbone
amide resonances that are undetectable in the 1H–15N HSQC spectrum of
Y48pCMF Cc but detectable in the 1H–15N HSQC spectrum of WT Cc are
colored in red. pCMF48 is shown in black, and the heme group is in green.
Unaffected, unassigned, and proline residues are in blue. (E) Internal mo-
bility comparison between Y48pCMF and WT Cc. S2-order parameter values
per residue for Y48pCMF (Upper) and WT (Lower) Cc are represented on the
respective NMR ribbon structures using a blue–red scale. Undetectable
backbone resonances are in gray. Heme atoms are in green, with the axial
ligands depicted as sticks.
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picosecond-to-nanosecond timescale (Fig. 3). Indeed, the Gly41-
to-Lys55 segment showed a drastic drop of HetNOE values in the
mutant species (Fig. 3A). Further, the amide R1 rates for the se-
quence stretch of Tyr46 to Lys55 in Y48pCMF Cc differ from
those in WT Cc (Fig. 3B). In addition, R2 analysis reveals three
regions undergoing conformational exchange in the microsecond-
to-millisecond timescale: His26 to Thr28, Thr40 to Trp59, and
Ile75 to Thr78 (Fig. 3C). This behavior agrees with the reduced
intensity or lack of detection of the amide signals belonging to
these stretches, compared with the WT form. Furthermore, some
regions within the protein displayed signals corresponding to
double conformations in the 2D 1H NOESY spectra—namely
Val20 to Asn31, Thr40 to Trp59, and Ile75 to Glu90—indicating
the presence of conformational equilibria between two different
structures occurring on a slow timescale with respect to the NMR
chemical shift. This dynamics involves residues located in a de-
fined region surrounding the noncanonical amino acid (Fig. 3D).
Altogether, the NMR relaxation measurements of Y48pCMF Cc
agree with the per-residue S2-order parameter values computed
with TENSOR (46) (Fig. 3E).
Hydrogen–deuterium exchange experiments showed that a
common core region is protected from solvent amide–hydrogen
exchange in both Cc species. Nevertheless, a substantial number
of amides become unprotected in pCMF48 Cc (SI Appendix, Fig.
S7). The newly accessible amide protons in the phosphomimetic
mutant (Gly29, Gly37, Arg38, Thr40, Gln42, and Trp59) are
located in the surroundings of pCMF48 and the nearby ΩG-loop,
in agreement with their high mobility in the microsecond-to-
millisecond timescale.
Tyr48 Phosphorylation Modulates the Interaction of Cytochrome c
with Its Mitochondrial Partners in the Electron Transfer Chain. Cc
carries electrons from Cbc1 to CcO within the ETC. To elucidate
more details about the process, we analyzed the molecular rec-
ognition between the soluble N-terminal domain of plant cyto-
chrome c1 (Cc1) or bovine CcO and the phosphomimetic human
Y48pCMF Cc. The human and plant N-terminal domains of Cc1
have a 62% overall sequence identity and similar charge distri-
butions on their molecular surfaces (47), whereas the bovine and
human CcO are evolutionarily related proteins, with 91 and 96%
sequence identity and homology, respectively.
Two binding sites for human and plant Cc on plant Cc1 have
been recently reported (47, 48). The proximal site is located near
the heme moiety and is compatible with electron transfer,
whereas the distal site lies far from the heme group and probably
constitutes a local energy minimum of the encounter ensemble.
To test how Tyr48 phosphorylation affects the conformation
of the Cc1–Cc complex, we recorded
1H–15N HSQC spectra
upon titration of 15N-labeled reduced Cc with unlabeled reduced
Cc1. Several amide signals exhibited significant chemical-shift
perturbations (CSPs), thus indicating a fast exchange rate
within the NMR timescale (Fig. 4 A and B). Average amide CSPs
(Δδavg) were larger than 0.075 ppm for 11 residues: Gln16,
Lys27, Gly29, Ala50, Lys55, Ile58, Lys72, Gly77, Met80, Ile81,
and Val83 (Fig. 4B). The fits of CSPs along the titration sug-
gested that Cc1 binds two Y48pCMF Cc molecules, as previously
found with the WT Cc species (47, 48) (Fig. 4C). Using NMR
spectroscopy, the dissociation constant (KD) values for the Cc1–
Y48pCMF Cc complex were estimated to be 0.6 and 102 μM for
the proximal and distal binding sites, respectively. All of the
perturbed residues, except Lys55 and Ile58, surround the heme
crevice, as previously described for the interaction between WT
Cc and Cc1 (47, 48) (Fig. 4D). In fact, this region constitutes a
very well conserved interaction surface in c-type cytochromes
(49–52). Lys55 and Ile58, in turn, are located in the ΩNY-loop,
which undergoes a conformational exchange in free Y48pCMF
Cc (Fig. 4D). In addition, significant CSPs (Δδavg ≥ 0.05 ppm)
were detected for Lys7, Lys13, His26, Lys39, Ala43, Thr78,
Lys86, Lys88, and Glu89. Interestingly, Lys8, Lys13, Lys27,
Fig. 4. Binding assays between Y48pCMF Cc and its respiratory partners. (A) Overlay of selected residues of 1H–15N HSQC spectra of 15N-labeled Y48pCMF Cc
along with titration with Cc1. Signals corresponding to different titration steps are colored according to the code indicated. (B) Plot of chemical-shift per-
turbations of 15N-labeled Y48pCMF Cc as a function of residue number. Proline and nonassigned residues are marked by asterisks. Color bars stand for the
Δδavg categories: insignificant Δδavg < 0.025 ppm, blue; small 0.025 ≤ Δδavg < 0.050 ppm, yellow; medium 0.050 ≤ Δδavg < 0.075 ppm, orange; and large ≥
0.075 ppm, red. (C, Upper) Curves representing the best global fit of several amide signals in the 1H dimension to a 2:1 ratio for the Y48pCMF Cc–Cc1 binding
model with two different global KD values. (C, Lower) Binding curves of Gln16. Lines represent the best fit to 1:1 (red) and 2:1 (black) binding models. (D) CSP
map of reduced Y48pCMF Cc upon addition of reduced Cc1 at a 1:1 ratio. Residues are colored according to Δδavg categories, as indicated in B. Proline and
nonassigned residues are in gray. (E) ITC measurements of the Y48pCMF Cc–Cc1 and Y48pCMF Cc–CcO complexes in their reduced states. Experimental data
were fitted to a 2:1 binding model. Thermograms (Upper); binding isotherms (Lower).






























Lys72, and Lys86 also experienced large CSPs, as previously
reported for the interaction between WT Cc and Cc1 (47, 48).
To obtain further data on the binding affinity and stoichiom-
etry of the interaction between the two redox proteins, iso-
thermal titration calorimetry (ITC) experiments were performed
on both redox states. The isotherms obtained by titrating reduced
Y48pCMF Cc with reduced Cc1 are displayed (Fig. 4E, Left). For
the interaction between Cc and Cc1, the isotherm clearly shows
two components with opposite signs in their respective enthalpy
terms, thereby indicating the presence of two binding sites, in
agreement with the NMR data herein presented and previous
reports on the WT species (47, 48). Indeed, all data fit a model
with two independent binding sites in the corresponding Cc
partner (SI Appendix, Table S5). The interaction between Y48pCMF
Cc and Cc1 was entropy-driven. At pH 7.4, the KD value at the
proximal site was half that observed for WT Cc, whereas that at
the distal site was four times higher (SI Appendix, Table S5). This
could be ascribed to the extra negative charge at position 48, which
alters the surface electrostatic potential of the hemeprotein (SI
Appendix, Fig. S8). Both Cc1–Y48pCMF Cc and Cc1–Cc com-
plexes in their oxidized states showed similar thermodynamic and
equilibrium parameters at both acidic and basic pH values. The
only exception was the KD value for the oxidized Cc1–Y48pCMF
Cc complex, at the proximal site of Cc1, which was approximately
four times lower than that for the oxidized Cc1–WT Cc adduct at
pH 8.5. ITC measurements of the oxidized Cc1–Y48pCMF Cc
complex were not run at pH 7.4 because the pKa for the alkaline
transition, which is specific to the ferric state (53), shifts to neutral
pH upon Tyr48 phosphorylation (31). Hence, the WT and phos-
phomimetic forms of oxidized Cc can differ in their sixth axial
ligand at pH 7.4 (SI Appendix, Table S5).
In addition, we analyzed the binding affinity of the cross-
complex between the reduced species of bovine CcO and human
Y48pCMF Cc by ITC. The isotherm inflection point lies at a 2:1
Y48pCMF-Cc:CcO ratio, thereby indicating the presence of two
binding sites on CcO, as previously found for WT Cc (47, 54, 55).
The best fit was achieved when the model used distinct KD values
for the two independent binding sites (SI Appendix, Fig. S9). The
resulting isotherms likewise fit to such a model, yielding different
micromolar-ranging KD values (Fig. 4E, Right and SI Appendix,
Table S6) and enthalpy-driven interactions. Both the CcO proxi-
mal and distal sites had lower affinities for Y48pCMF Cc than the
WT species, as previously reported (47) (SI Appendix, Table S6).
Altogether, these data agree with previous steady-state kinetic
analysis that demonstrated a binding model with more than one
molecule of Cc per molecule of Cbc1 (56) and with kinetic-based
models that proposed the existence of alternative, nonproductive
binding sites for horse Cc in bovine CcO (55). In addition, direct
binding studies performed by gel filtration between several
mammalian Ccs and bovine CcOs evidenced a 2:1 stoichiometry,
in which Cc bound to a first site with a dissociation constant within
the nanomolar range and to a second site with less affinity (54).
To assess the functional ability of Y48pCMF Cc to reduce re-
spiratory complex IV, we tested the CcO activity of isolated
complex IV or Cc-free mitochondria (ΔCc) from yeast cells grown
with glucose as a carbon source (Fig. 5A and SI Appendix, Fig.
S10A). In both cases, the Cc oxidation rate was at least twofold
higher with Y48pCMF Cc than with WT Cc, thereby suggesting
that Tyr48 phosphorylation enhances the ability of Cc to donate
electrons to complex IV. Direct measurements of O2 consumption
were consistent with such data (SI Appendix, Fig. S10B). Inter-
estingly, the CcO activity was positively regulated by the human
membrane proteins hypoxia-inducible domain family members 1A
and 2A (HIGD1A and HIGD2A), which promote cell survival
under hypoxia. HIGD2A was successfully expressed in cell-free
expression systems combined with n-dodecyl-β-D-maltoside, as
previously reported for HIGD1A (57) (SI Appendix, Fig. S11
A–C). HIGD1A significantly increased the rate of CcO-catalyzed
oxidation of Y48pCMF Cc (Fig. 5B), as reported for WT Cc (58).
Strikingly, HIGD2A induced an even stronger positive effect than
HIGD1A (Fig. 5B). Nevertheless, the HIGD-dependent increase
in CcO activity was slightly lower with Y48pCMF Cc (Fig. 5B).
This may be due to HIGD-dependent changes in either the
complex IV affinity toward Cc or the restraints of Cc diffusion
(channeling) from Cc1 to complex IV. A direct Cc–HIGD inter-
action can also not be excluded.
To confirm the HIGD-mediated regulation of the CcO ac-
tivity in a cellular context, we isolated mitochondria from dif-
ferent yeast strains grown either with glucose (YPD medium),
which supports fermentation and respiration, or with the non-
fermentable carbon sources lactate and galactose (YP-Gal) (59).
Under both metabolic conditions, the isoformic respiratory
supercomplex factors 1 (Rcf1, formerly Aim31) and 2 (Rcf2,
formerly Aim38) are constitutively expressed (Fig. 5C, Inset), in
agreement with their role in CcO activity and supercomplex
stability (59–61). Rcf1 is a yeast ortholog of the human HIGD1A
and HIGD2A proteins, whereas Rcf2 is specific to yeast. The
external membranes of isolated mitochondria were then per-
meabilized to allow the entry of exogenous WT or Y48pCMF Cc.
Under these conditions, mitochondria isolated from a yeast
strain deficient in both Rcf1 and Rcf2 (ΔRcf1/2), as verified by
Western blot, displayed an endogenous CcO activity lower than
that isolated from WT yeast (WTRcf), no matter which type of
exogenous hemeprotein—WT or Y48pCMF Cc—was used for
supplementation (Fig. 5C). This indicates that Rcf1 and Rcf2 act
as positive modulators of CcO activity, similar to human HIGD
proteins. In mitochondria isolated from yeast grown with non-
fermentable carbon sources, the Rcf-mediated increase in CcO
activity was less prominent when Y48pCMF Cc rather than WT
Cc was added as an exogenous electron donor, in agreement with
the in vitro behavior of isolated proteins (Fig. 5B). This suggests
that Tyr48 phosphorylation makes Cc less sensitive to the en-
hancer mechanism of the Rcf proteins and/or to the ability of
Rcfs to stabilize the Cbc1–CcO supercomplexes (Fig. 5C). In
fact, Rcf1 and Rcf2 promote the supercomplex assembly, pref-
erably in mitochondria from yeasts grown in a respiratory-based
medium (Fig. 5D and SI Appendix, Fig. S11D). This is especially
remarkable when comparing the band intensities in an anti–
COX-II immunoblot (Fig. 5D). Note that such OxPhos super-
complexes could show a certain degree of heterogeneity in their
composition, because the gene transcription of COX-Va and
COX-Vb—which encode for two CcO isoforms—is repressed
and active, respectively, in the aerobic-to-anaerobic metabolic
transition (62). Moreover, the faint band pattern of ΔRcf1/
2 strains grown in YPD medium on blue native (BN)/PAGE
corresponds to supercomplexes, thus suggesting that other fac-
tors may contribute to their assembly (Fig. 5D and SI Appendix,
Fig. S11D).
Altogether, our data suggest that phosphorylation of Cc at
Tyr48 modulates the mitochondrial ETC (Fig. 5E). Such a post-
translational modification allows a fast adaptation of the hem-
eprotein function to changing cell conditions. The population of
Cbc1–CcO supercomplexes is less prominent in the presence than
in the absence of glucose, although Rcf proteins are still expressed.
In any case, Cc channeling from Cbc1 toward CcO is impaired. At
a physiological pH, Tyr48 phosphorylation thus favors binding of
Cc to the proximal rather than to the distal site of Cc1. Under
respiration-based growth, the Rcf proteins preferably associate
directly with the OxPhos supercomplex, bridging Cbc1 and CcO.
However, the weaker Y48pCMF Cc–CcO binding, along with the
loss of the distal site on Cc1 due to phosphorylated Cc, impairs
the channeling of Cc molecules that functionally connects Cbc1
with CcO, which has been proposed to occur with WT Cc (47,
48). As a consequence, Y48pCMF Cc is less efficient than WT
Cc as an electron carrier toward CcO in the context of OxPhos
supercomplexes.
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Tyr48-Phosphorylated Cytochrome c Acts as an Improved Peroxidase-
Like Enzyme, in Particular When Bound to Cardiolipin-Containing
Liposomes. Assembly of the mitochondrial protein membrane
complexes Cbc1 and CcO into OxPhos supercomplexes enables
more efficient electron flow and decreases ROS levels generated
by the ETC (63). The phospholipid CL, located in the inner
mitochondrial membrane, also stabilizes the resulting super-
complexes (64) in a HIGD/Rcf-independent manner (59). In
addition, CL interacts with Cc in a two-step binding reaction
(65): In the first step, the so-called A site at the Cc surface makes
transient electrostatic contacts with the membrane; in the second
step, hydrophobic forces drive the formation of a tight and stable
Cc–CL complex, with one of the CL acyl chains entering the
hydrophobic groove of Cc (termed the C site) (66–68). C-site
binding then triggers Cc-regulated CL peroxidation under oxi-
dative stress and induces early apoptosis (40). Interestingly,
several residues of Cc (Lys22, Lys27, and His33) become pro-
tonated at low pH to form an extra binding site—the so-called L
site—that facilitates the electrostatic interaction of Cc with mi-
tochondrial membranes (69).
Within this framework, we analyzed how tyrosine phosphory-
lation can fine-tune the affinity of Cc toward CL-containing li-
posomes, analyzing binding of Cc species to liposomes in Hepes
buffer at a physiological pH value by electrophoretic mobility shift
assays (EMSAs) in native agarose gels (Fig. 6 A and B). To
compare the binding properties of Cc species to the CL-containing
liposomes of 4:1 DOPC:TOCL (1,2-dioleoyl-sn-glycero-3-phos-
phocholine:1,1′,2,2′-tetraoleoylcardiolipin) or to liposomes of
DOPC alone, we measured the mobility profiles of Cc at different
Cc:lipid ratios. Although both WT and Y48pCMF Cc bound to
DOPC:TOCL and DOPC vesicles, their binding affinity for the
CL-free DOPC liposomes seemed to be lower (Fig. 6 A and B).
Notably, the presence of free hemeprotein at high lipid concen-
trations suggested that Y48pCMF Cc has a lower affinity than WT
toward DOPC:TOCL liposomes (Fig. 6B), as recently observed
for the phosphomimetic mutant S47D Cc (70). Another interest-
ing finding is the unspecific interaction of Cc—either the WT or
Y48pCMF species—with DOPC vesicles (Fig. 6 A and B).
ITC measurements corroborated these EMSA data. ITC ex-
periments were performed under aerobiosis to mimic physiological
conditions, despite using degassed samples. This may result in
partial oxidation of Cc upon binding to liposomes, as previously
reported (71). ITC analysis yielded the apparent KD values for the
first binding event of 427 μM (WT Cc) and 780 μM (Y48pCMF
Cc) (Fig. 6C). Data for the interaction of WT Cc with liposomes
are consistent with the KD values reported before (68, 72–74), but
they diverge from the lower KD values reported in the literature
Fig. 5. CcO activity with WT or Y48pCMF Cc as the
electron donor. (A) CcO activity of isolated complex
IV and of mitochondria lacking Cc (ΔCc) upon ad-
dition of exogenous WT (blue bars) or Y48pCMF Cc
(red bars). Western blot results confirmed the lack of
endogenous Cc in ΔCc mitochondria (Inset). (B) In
vitro modulation of CcO activity by HIGD1A and
HIGD2A. WT Cc (blue bars) or Y48pCMF Cc (red
bars), along with HIGD1A or HIGD2A at the in-
dicated ratios, was added to isolated complex IV.
(C) Effect of the modulators Rcf1 and Rcf2 on the CcO
activity of mitochondria isolated from yeasts grown
in YPD or YP-Gal media with either WT Cc (blue
bars) or Y48pCMF Cc (red bars). All data represent
the mean ± SD of three independent experiments.
In all cases, CcO activity was detected only upon
addition of exogenous Cc but not with endogenous
Cc. (C, Inset) Western blots of WTRcf mitochondria
(lane 1) and mitochondria lacking Rcf1 and Rcf2
(ΔRcf1/2) (lane 2). (D) BN/PAGE and Western blots of
mitochondria from WTRcf and ΔRcf1/2 strains, using
antibodies against Rcf2 and COX-II. Bands submitted
to tryptic digestion (SI Appendix, Fig. S11D) are
highlighted by asterisks. (E) Scheme of the interac-
tions within the electron transport chain involving
Cbc1, CcO, Rcf proteins, and WT or Y48pCMF Cc, as a
function of glucose (Glu) availability. The Rcf pro-
teins facilitate the interaction between Cbc1 and
CcO to form OxPhos supercomplexes, mainly under
glucose deprivation (Right). The thickness of solid
arrows refers to the electron transfer rate at the Cc-
binding proximal sites of Cbc1 and CcO by WT or
Y48pCMF Cc—the longer and thicker the arrow, the
more efficient the electron transfer. The dashed line
highlights the channeling of WT Cc molecules.






























(75) and the A/C two-site binding model described by Kinnunen
and coworkers (66, 67). Such discrepancies are still unresolved,
and further research is necessary to harmonize data from all
these different binding assays in a unified and single model. The
interaction with CL resulted in apparent ΔH values equal to
2.75 kcal·mol–1 for WT Cc and 38.97 kcal·mol–1 for Y48pCMF Cc.
The differences in KD indicate a small change in binding energies
(of ∼6 kcal·mol–1). Hence, the changes in ΔH are indicative of
enthalpy–entropy compensation effects, which are compatible with
the electrostatic change resulting from the extra carboxylate group
of the Y48pCMF species. Further, an exothermic process can be
observed, with longer peak equilibrium times upon successive lipid
additions. In this case, the apparent ΔH values with the WT and
Y48pCMF Cc species were equal to −6.97 and −47.84 kcal·mol–1,
respectively, but the apparent KD value (of ∼1 mM) was practically
the same with the two Cc species. Altogether, our EMSA and ITC
assays indicate that Y48pCMF Cc binds to CL-containing lipo-
somes with a slightly lower affinity than WT Cc.
WT Cc undergoes CL-dependent conformational changes that
allow H2O2 to access the heme crevice (74). Hence, we addressed
whether the affinity differences between WT and Y48pCMF Cc
for CL could affect their peroxidase activity. In the absence of CL-
containing liposomes, Y48pCMF Cc exhibited a threefold higher
peroxidase activity than WT Cc (Fig. 6D). However, the presence
of DOPC:TOCL vesicles, at a 1:100 Cc:lipid ratio, increased the
enzymatic activity of both WT and Y48pCMF Cc, similar to that
observed for other phosphomimetic Cc mutants (70). Note that
the slightly lower peroxidase activity increment observed for
Y48pCMF Cc is likely due to its higher population of free protein
compared with WT Cc (Fig. 6 B and D).
Tyr48 Phosphorylation Is an Antiapoptotic Posttranslational Modification.
Phosphorylated Cc may be more easily released from mitochondria
because of its lower affinity toward CL, as inferred from EMSA and
ITC assays. Translocation to the cytosol could thus enable phos-
phorylated Cc to interact with Apaf-1 and to assemble the caspase-
activating apoptosome. However, cytosolic caspase-3 activation was
decreased by about 60% in the presence of the Y48pCMF Cc
mutant (Fig. 6E). This is in agreement with the behavior previously
reported for the Y48E Ccmutant, which exhibits a lower ability than
WT Cc to activate not only caspase-3 (26) but also procaspase-9 by
nonfunctional apoptosome assembly (27). These results could thus
be indicative of an antiapoptotic function of Cc when phosphory-
lated at position 48.
Discussion
Here we tackle the structural and functional characterization of the
Y48pCMF variant of human Cc. This mutation mimics protein
phosphorylation at Tyr48 by adding a negative charge and slightly
increasing the side-chain size while keeping the aromatic ring. A
recent spectroscopic analysis of Y48pCMF Cc showed a singular
shift of the typical alkaline transition pKa to physiological pH values
(31), as is the case with the Y48E Cc mutant (26, 27). Here, we
report NMR-based structure computations that indicate that
Tyr48 phosphorylation maintains the core foldon of Cc but in-
creases internal motions in the loopsΩNY,ΩR, andΩG. Specifically,
the ΩNY-loop, the most unstable folding unit of the hemeprotein,
becomes looser and reaches conformational equilibria in Y48pCMF
Cc. Enhanced motions at the ΩG- and ΩR-loops could be associ-
ated with the shift in the alkaline transition pKa. Indeed, these two
loops hold the residues that provide the iron axial ligands, which
are observed to at least partially lose their metal coordination in
the alkaline form (76). This is in contrast to XAS data that suggest
that axial coordination remains untouched. However, the cryo-
genic temperatures at which the XAS spectra were recorded may
Fig. 6. Liposome-binding assays with caspase-3 activity induced by WT and
Y48pCMF Cc. (A and B) EMSA of Cc in the presence of increasing concen-
trations of lipids. DOPC:TOCL (4:1) or DOPC liposomes were incubated with
WT (A) or Y48pCMF (B) Cc. Note that free Cc species moved to the cathode,
whereas liposome-bound Cc migrated to the anode. Lanes marked by rect-
angles correspond to the Cc:lipid ratio at which the peroxidase activity was
determined (see below). (C) Calorimetric assays for lipid binding to Cc. (C,
Upper) ITC thermograms, corresponding to titrations of DOPC:TOCL 4:1 li-
posomes (black), WT Cc (blue), or Y48pCMF Cc (red). (C, Lower) Binding
isotherms with WT Cc (blue dots) or Y48pCMF Cc (red dots). Continuous
lines represent the best fits to a sequential binding, as computed with
NanoAnalyze software (TA Instruments) with a stoichiometry of 30 molecules of
lipid per molecule of Cc. All data represent the mean ± SD of three independent
experiments. (D) Relative peroxidase activities of WT Cc (blue) or Y48pCMF Cc (red)
in the presence of liposomes containing DOPC (empty bars) or DOPC:TOCL (4:1)
(filled bars). (E) Relative caspase-3 activity in HEK293 cell extracts devoid of en-
dogenous Cc upon addition of exogenousWT Cc (blue) or Y48pCMF Cc (red). A lack
of caspase autoactivation was verified in a run without the addition of Cc (gray).
Western blots confirmed the lack of endogenous Cc in cytoplasmic cell extracts after
immunoblottingwith anti–α-tubulin (cytosolicmarker) and anti-Cc antibodies (Inset).
Lane 1, cytoplasmic cell extracts; lane 2, Cc; lane 3, BSA as a negative control. All data
represent the mean ± SD of three independent experiments.
Fig. 7. Schematic diagram illustrating the changes induced in cell function
by phosphomimetic Y48pCMF Cc. The negative charge at position 48 de-
creases CcO activity by disrupting Cc channeling in OxPhos supercomplexes
(Left), enhances ROS scavenger activity by increasing the peroxidase activity
of CL-bound Cc (Middle), and promotes the antiapoptotic function of
Y48pCMF Cc by inhibiting its ability to activate the caspase-3 cascade (Right).
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amplify the most stable structures and reduce contributions from
minority species with a high disorder, which are undetectable.
The local but substantial changes in conformation and dy-
namics of the regions surrounding the Y48pCMF mutation in-
creased the solvent accessibility of the porphyrin ring, thereby
enhancing cytochrome peroxidase activity. Thus, Y48pCMF Cc
proficiently scavenges ROS and avoids damage of cellular
components (Fig. 7). Our findings also indicate that Y48pCMF
Cc binds to mitochondrial CL with a lower affinity than WT Cc
but that Y48pCMF Cc shows a higher peroxidase activity upon
binding to liposomes. According to the literature, both events
may facilitate Cc translocation to the cytoplasm during apoptosis
(77). However, phosphorylation at Tyr48 hinders the proa-
poptotic activity of extramitochondrial Cc, similar to the function
of HIGD1A protein in ischemia and tumorigenesis (78). Indeed,
both HIGD1A and Y48pCMF Cc act as prosurvival proteins by
preventing apoptotic caspase activation (Fig. 7) (79).
As expected, the Y48pCMF mutation affects the binding mode
of Cc to its well-known respiratory partners Cbc1 and CcO. Not
surprisingly, the enhanced internal motions of the loops ΩNY and
ΩR and the electrostatic change at the interaction patch resulting
from the additional carboxyl group affect the interaction of
Y48pCMF Cc with the two membrane complexes. The mutation-
induced changes in electrostatics and in solvation at the interface
also concur for the interaction of reduced Y48pCMF Cc with the
distal sites of CcO (and Cc1), as inferred from the high decrease in
dissociation enthalpies and the strong (or moderate) enthalpy–
entropy compensation herein reported. Indeed, the binding of
Y48pCMF Cc on the Cc1 surface is weak and functionally irrele-
vant at the distal site but is favored at the proximal site (Fig. 5E).
When the turnover of the redox carrier at the main site is con-
sidered, the high affinity of reduced Y48pCMF Cc inhibits its own
replacement by oxidized Cc molecules, thereby impairing the
electron transport.
The Cc–CcO complex keeps its interface solvated, according to
the recent X-ray diffraction structure (80), which displays a pro-
truding lysine side chain in CcO pointing to Tyr48 in Cc. A salt
bridge involving phosphorylated Tyr48 would restrain the ΩNY-
loop. The increase in the KD of the complex between Y48pCMF
Cc and CcO (this work) and the decrease in the Michaelis con-
stant (KM) of phosphorylated Cc with CcO (81) indicate that KM is
mainly governed by the catalytic step. This agrees with the larger
CcO-driven oxidation rate of Y48pCMF Cc compared with that of
WT Cc at the limiting protein concentrations in the enzymatic
activity assays used here. In this context, the ca. 60-mV decrease in
the E0 of Y48pCMF Cc (31) may facilitate the electron flow from
Cc to CcO, although it may impair Cc reduction by Cbc1. In other
words, Y48pCMF Cc exhibits a reduced ability as oxidizing agent
(it is less capable than WT Cc of receiving electrons from Cc1) but
displays an increased capacity as reducing agent (it is a better
electron donor to CcO than WT Cc). It is well-known that the
catalytic step can be tuned by conformational changes of Cc upon
binding to CcO (52). Strikingly, these changes resemble the
prominent internal dynamics of Y48pCMF Cc, which could also
explain not only the change in E0 but also the shift in the alkaline
transition pKa of oxidized Y48pCMF Cc (31). Therefore, the
transition from reduced to oxidized Y48pCMF Cc, which is ac-
companied by a change in the iron axial ligand at physiological
pH, is expected to have a high-energy barrier (82). Hence, such
conformational changes might be the limiting step for Y48pCMF
Cc oxidation inside the complex.
Under nutrient and oxygen depletion, a dysfunctional mito-
chondrial ETC and OxPhos can lead to many human diseases, in-
cluding pathologies such as ischemia and cancer (24). The nexus in
both disorders could be the control of mitochondrial ET rate by Cc
phosphorylation (23), which has indeed been reported to efficiently
fine-tune respiratory rates (81). Even though HIGD-mediated as-
sembly of Cbc1 and CcO into OxPhos supercomplexes preferably
occurs under low-glucose conditions, the decrease in both the CcO
activity and binding affinity toward Cc1 and CcO resulting from the
enhanced dynamics of Y48pCMF Cc could explain the disruption
of Cc channeling inside the Cbc1–CcO supercomplex, thus slowing
down the ETC flow (Fig. 7).
Intriguingly, not only respiratory supercomplex formation
(60, 61)—whose structure has recently been solved (83, 84)—
but also Cc phosphorylation, and the resulting decrease in the
ETC rate, could help to keep ROS levels low and guarantee
cell survival.
Tyr48-phosphorylated Cc could be targeted as a biomarker of
mitochondrial dysfunction for associated pathological states such
as ischemia/reperfusion and cancer. Deciphering the details of the
phosphorylated Cc-controlled complex network requires accurate
structural and dynamic analyses to eventually develop robust
therapeutic approaches to foster or silence—as required—the
prosurvival action of phosphorylated Cc reported here.
Methods
Methods and associated references are available in SI Appendix, Methods. All
biological samples were obtained from bacteria, yeast, or human cell extracts,
in full compliance with University of Seville Ethical Committee bylaws.
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